You KEEP falling into the same trap. You keep cherry-picking things that you believe support your wishes, and ignoring the preponderance of evidence as a whole. You also fail to point out that when I made those "the jury is out" comments, it was before the large RCT trials of HCQ that have since shown it to be . . . . worthless for COVID-19, and dangerous overall.
But hey, what does the guy here with an M.D. and a Ph.D. in molecular biology, that has real life experience with genetic manipulation of viruses (adenovirus in this case) know, right?
If you want a "cheap", simple, and effective single drug treatment, use dexamethasone (a 70 year old steroid drug). If you want to further improve your chances, add in Remdesivir. That is the CURRENT, STANDARD OF CARE.
You are wrong about the FDA adverse event reporting on HCQ. ALL of them used to support the removal of HCQ as a recommended treatment were ACUTE events after Jan 1, 2020 (i.e. during the pandemic). You have the American College of Physicians, the American Heart Association, and MANY other physician groups ALL recommending against HCQ.
I don't know you, and I could care less if you take HCQ (have fun with that btw).
I do not consider discerning between efficacy of dosing X of a medication and dosing 2X to be cherry picking data. if you can share a preponderance of data at the dosing Zelenko & HF used showing no efficacy, that would be disappointing, but useful information to know. please reply with data rather than ilstrong characterizations without the inclusion of data.
as to adverse event reporting, can you provide a link to data that contradicts the assertions from the Yale epidemiologist
finally, you’ve not addressed the Oxford University paper re adverse events being only 1/10,000 in a massive 320,000 patient sample size taking HCQ and Azith.